Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's
Biotech
Patient death prompts Roche to adjust Alzheimer's trial
A patient's death prompted an “in-depth evaluation" and a change to the trial design, according to a Roche presentation.
Gabrielle Masson
Oct 30, 2024 11:40am
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Oct 28, 2024 10:00am
J&J jettisons several programs, including ph. 2 Alzheimer's work
Oct 15, 2024 2:00pm
Actinogen reports new data in bid to salvage depression drug
Aug 26, 2024 11:03am
Researchers receive $6.9M NIA grant for tau-targeting drug
Aug 21, 2024 1:02pm
AC Immune sees 'landmark' potential in brain-penetrating ADC
Jul 31, 2024 10:00am
